Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo - Tao, Yong; Lamas, Veronica; Du, Wan; Zhu, Wenliang; Li, Yiran; Whittaker, Madelynn N.; Zuris, John A.; Thompson, David B.; Rameshbabu, Arun Prabhu; Shu, Yilai; Gao, Xue; Hu, Johnny H.; et al. (Nature communications, 2023)
Keywords: 14; 14/1; 14/19; 14/28; 38/22; 38/23; 38/77; 42; 45; 45/23; 631/208/4041/3196; 631/61/2297; 64/60; 692/699/375/2764; Cell survival; CRISPR; CRISPR-Cas Systems - genetics; Deafness; Deafness - genetics; Editing; Genetic modification; Genome editing; Genomes; Hair; Hair cells; Hearing loss; Hearing Loss - genetics; Hearing Loss - therapy; Hearing protection; Humanities and Social Sciences; Humans; Liposomes; multidisciplinary; Mutation; Recovery; Ribonucleoproteins - genetics; RNA, Guide, CRISPR-Cas Systems; Science; Science (multidisciplinary)